Stable Preparation of Fetal Hemoglobin to Improve Tissue Oxygenation

Summary

Dr. Hawiger and colleagues developed a novel form of cell-penetrating fetal hemoglobin.  This technology is useful for the treatment of hemoglobinopathies or to increase oxygen delivery in any condition.  The preparation is stable and sterile.  Upon reconstitution, the treatment can be delivered I.V. or through transfusion.  

Inventors: 
Jack HawigerQing Lin
Licensing manager: 
Janis Elsner

Featured Video

Vanderbilt Patent Activity

View Vanderbilt University Patents

CTTC on Twitter